This study attempts to quantify changes in regional cerebral mu opiate receptors and glucose metabolism using 11C-carfentanil and 18F fluorodeoxyglucose (FDG) PET in familial Alzheimer's Disease and to relate these changes to cognitive and neuropsychological parameters of disease.
Showing the most recent 10 out of 65 publications